anonymous
Guest
anonymous
Guest
In 2015 the company's UPC business grew about 20%. In 2016 that business grew 5% and that too was on a declining trend, with fourth quarter DECLINING 2%. UPC accounts for about one-half of Cogentix's revenue and this decline is taking a big bite out of their overall business. Let's face it, Medtronic's Nuro System is killing Cogentix's UPC, and it is not over yet. The fat lady is not yet finished singing. Those walls that DH thought he was building are coming crumbling, crumbling down. And guess what, PrimeSight has seen its best days. That too is on a declining growth trend.